Ervin TJ - Search Results

1

Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA).

Ervin TJ, Blum RH, Meshad MW, Kufe DW, Johnson RK, Canellos GP. Ervin TJ, et al. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1067-71. Cancer Treat Rep. 1980. PMID: 7459892

2

Phase I trial of combination therapy with PALA and 5-FU.

Meshad MW, Ervin TJ, Kufe D, Johnson RK, Blum RH, Frei E 3rd. Meshad MW, et al. Among authors: ervin tj. Cancer Treat Rep. 1981 Mar-Apr;65(3-4):331-4. Cancer Treat Rep. 1981. PMID: 6263472

3

Phase II trial of combination therapy with continuous-infusion PALA and bolus-injection 5-FU.

Weiss GR, Ervin TJ, Meshad MW, Kufe DW. Weiss GR, et al. Among authors: ervin tj. Cancer Treat Rep. 1982 Feb;66(2):299-303. Cancer Treat Rep. 1982. PMID: 7055815

4

A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU.

Weiss GR, Ervin TJ, Meshad MW, Schade D, Branfman AR, Bruni RJ, Chadwick M, Kufe DW. Weiss GR, et al. Among authors: ervin tj. Cancer Chemother Pharmacol. 1982;8(3):301-4. doi: 10.1007/BF00254054. Cancer Chemother Pharmacol. 1982. PMID: 7127661

5

Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).

Ervin TJ, Weichselbaum R, Miller D, Meshad M, Posner M, Fabian R. Ervin TJ, et al. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):787-91. Cancer Treat Rep. 1981. PMID: 6168371

6

Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate.

Ervin T, Canellos GP. Ervin T, et al. Cancer. 1980 Apr 1;45(7):1556-7. doi: 10.1002/1097-0142(19800401)45:7<1556::aid-cncr2820450707>3.0.co;2-b. Cancer. 1980. PMID: 7370915

7

Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.

Kirkwood JM, Canellos GP, Ervin TJ, Pitman SW, Weichselbaum R, Miller D. Kirkwood JM, et al. Among authors: ervin tj. Cancer. 1981 May 15;47(10):2414-21. doi: 10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w. Cancer. 1981. PMID: 6974039

8

Chemotherapy for advanced carcinoma of the head and neck. A clinical update.

Ervin TJ, Miller D, Weichselbaum R, Fabian RL, Meshad M. Ervin TJ, et al. Arch Otolaryngol. 1981 Apr;107(4):237-41. doi: 10.1001/archotol.1981.00790400039009. Arch Otolaryngol. 1981. PMID: 6971090

9

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.

Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H, Ervin T, Kufe D, Rifkind RA, Marks PA. Andreeff M, et al. Blood. 1992 Nov 15;80(10):2604-9. Blood. 1992. PMID: 1421378 Free article. Clinical Trial.

10

Phase I study of continuous-infusion cisplatin.

Posner MR, Skarin AT, Clark J, Ervin TJ. Posner MR, et al. Among authors: ervin tj. Cancer Treat Rep. 1986 Jul;70(7):847-50. Cancer Treat Rep. 1986. PMID: 3013401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page